Cargando…
Current and future treatment options for polycythemia vera
Patients with polycythemia vera (PV), a myeloproliferative neoplasm characterized by an elevated red blood cell mass, are at high risk of vascular and thrombotic complications and have reduced quality of life due to a substantial symptom burden that includes pruritus, fatigue, constitutional symptom...
Autores principales: | Griesshammer, Martin, Gisslinger, Heinz, Mesa, Ruben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420843/ https://www.ncbi.nlm.nih.gov/pubmed/25832853 http://dx.doi.org/10.1007/s00277-015-2357-4 |
Ejemplares similares
-
Thromboembolic events in polycythemia vera
por: Griesshammer, Martin, et al.
Publicado: (2019) -
Polycythemia Vera (PV): Update on Emerging Treatment Options
por: Benevolo, Giulia, et al.
Publicado: (2021) -
Ruxolitinib-Associated Infections in Polycythemia Vera: Review of the Literature, Clinical Significance, and Recommendations
por: Sadjadian, Parvis, et al.
Publicado: (2020) -
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
por: Vaddi, Kris, et al.
Publicado: (2016) -
Acute oxygenator occlusion in two cases of polycythemia vera: Bailout strategies
por: Kaiser, Philipp, et al.
Publicado: (2020)